BLOG

Sign up for the V2V Insight Newsletter!

Have you checked out our newsletter?

Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.

"*" indicates required fields

Name*

Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog. 

The Latest News

Launch Broadcast? Yes! Mid Product Life-Cycle? ABSOLUTELY!

One of the most persistent myths about broadcasts is that they are only good for new product launches. The reality is that while product launches are indeed a great time to deploy wide-reaching national broadcasts, their utility extends far beyond this single use. National broadcasts are perfect for announcing newly

READ MORE »
Pills scattered on a table with money

What’s Trending in BioPharma – February 2026

The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model for the 340B Drug Discount program. Here’s what’s shaping the latest in healthcare. Source: BioPharma International In a recent BioPharm International interview, Janice MacLennan, founder

READ MORE »
FDA Approval Stamp

What’s Trending in BioPharma – January 2026

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: BioSpace The biopharma sector is entering 2026 with renewed strength following a market rebound. Analysts point to oncology, neuroscience, and immunology

READ MORE »
V2V President Daniel Rehal holds the 2024 BBB Torch Award for Ethics and Excellence

V2V Wins 2025 International Torch Award

Vision2Voice Healthcare Communications is honored to be named one of five winners of the 2025 BBB International Torch Awards for Ethics! V2V has previously been awarded in the USA at the regional level on five previous occasions, but this recognition marks our first on the international stage. For over a decade,

READ MORE »
KOL ID Roundtable Panel

Roundtable Q&A: The Future of KOL/KEE ID and Mapping

The BioPharma world is a fast-evolving one, but Key Opinion Leaders (KOLs) and Key External Experts (KEEs) remain the core component of transforming awareness into action. What is KOL/KEE Identification and what are some scenarios in which it might be done? KOL/KEE Identification and mapping is pinpointing highly respected, distinguished,

READ MORE »
FDA Approval Stamp

BioPharma Trends in the News – October 2025

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Reuters Several major pharmaceutical companies are responding to recent U.S. policy shifts by cutting drug prices and announcing plans to sell

READ MORE »
Magnifying glass identifying an expert

How to Identify Top Experts

Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

READ MORE »